Lessons from the Closure of the Cellulose Sulphate Microbicide Trial in South Africa
Author Information
Author(s): Gita Ramjee, Roshini Govinden, Neetha S. Morar, Anthony Mbewu
Primary Institution: HIV Prevention Research Unit, Medical Research Council, Durban, KwaZulu-Natal, South Africa
Conclusion
The closure of the cellulose sulphate trial highlighted the need for better communication strategies in HIV prevention research.
Supporting Evidence
- The trial was stopped due to a higher number of HIV seroconversions in the cellulose sulphate arm compared to the placebo.
- The study emphasized the importance of community education and clear communication about trial outcomes.
- Negative media coverage led to public misconceptions about the trial and its participants.
Takeaway
The study shows that when a medical trial is stopped, it's important to communicate clearly with everyone involved to avoid misunderstandings and fear.
Methodology
The study involved a randomized controlled trial with 1,333 women across five sites, comparing cellulose sulphate to a placebo.
Potential Biases
Media sensationalism may have distorted public perception of the trial and its participants.
Limitations
The study did not explore the long-term effects of the trial closure on participants and communities.
Participant Demographics
Participants were women from South Africa, Uganda, Benin, and India.
Statistical Information
P-Value
p < 0.10
Statistical Significance
p < 0.10
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website